DeepMed Research

YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Topical Antibacterial Agents for Prevention of COVID-19

Phase 1

Completed

Conditions: SARS-CoV2 Infection
COVID-19

Interventions: Other: Vaseline
Drug: Neosporin

First Posted Date: 2022-07-08

Last Posted Date: 2023-10-03

Lead Sponsor: Yale University

Target Recruit Count: 67

Registration Number: NCT05449392

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Safety, Tolerability and Pharmacokinetics of NYX-783 and Oxycodone DDI Study

Phase 1

Completed

Conditions: Opioid Use Disorder

Interventions: Drug: Placebo
Drug: NYX-783
Drug: Oxycodone

First Posted Date: 2022-07-07

Last Posted Date: 2025-03-25

Lead Sponsor: Yale University

Target Recruit Count: 9

Registration Number: NCT05447286

Locations: 🇺🇸
Cmhc/Cnru, New Haven, Connecticut, United States
🇺🇸
The Yale Stress Center: Yale University, New Haven, Connecticut, United States

Genomic Predictors of Recurrent Pregnancy Loss

Recruiting

Conditions: Recurrent Pregnancy Loss

First Posted Date: 2022-07-05

Last Posted Date: 2024-12-27

Lead Sponsor: Yale University

Target Recruit Count: 1000

Registration Number: NCT05444283

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸
Gaelle Massoud, Baltimore, Maryland, United States
🇺🇸
University of Colorado, Aurora, Colorado, United States

and more 8 locations

Personal Health Libraries for Formerly Incarcerated Individuals

Not Applicable

Not yet recruiting

Conditions: Personal Health Information
Incarcerated Individuals

Interventions: Device: Personal Health Library (PerHL) + MyChart
Device: Epic®MyChart

First Posted Date: 2022-07-01

Last Posted Date: 2025-02-17

Lead Sponsor: Yale University

Target Recruit Count: 100

Registration Number: NCT05441306

Locations: 🇺🇸
Yale School of Medicine, New Haven, Connecticut, United States

Sex Differences in E-cig Perception: Study 1

Not Applicable

Recruiting

Conditions: E-Cig Use
Nicotine Addiction
Cigarette Smoking
Sex Differences

Interventions: Other: E-liquid Flavor 1
Other: E-liquid Flavor 2
Other: E-liquid Flavor 3

First Posted Date: 2022-06-27

Last Posted Date: 2025-05-02

Lead Sponsor: Yale University

Target Recruit Count: 60

Registration Number: NCT05432830

Locations: 🇺🇸
Connecticut Mental Health Center, New Haven, Connecticut, United States

Novel in Vivo Synaptic Imaging in Experienced Meditators

Phase 1

Completed

Conditions: Behavior, Health

Interventions: Drug: Radiotracer

First Posted Date: 2022-06-14

Last Posted Date: 2024-07-18

Lead Sponsor: Yale University

Target Recruit Count: 20

Registration Number: NCT05418608

Locations: 🇺🇸
Yale University PET Center, New Haven, Connecticut, United States

WithDRawal Impact Of Postoperative Beta-Blocker

Not Applicable

Terminated

Conditions: Coronary Artery Bypass

Interventions: Other: Discontinuing all beta-blocker

First Posted Date: 2022-06-10

Last Posted Date: 2025-04-06

Lead Sponsor: Yale University

Target Recruit Count: 43

Registration Number: NCT05414331

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

Investigating the Impact of a Shared Decision-Making Tool

Not Applicable

Completed

Conditions: Osteoarthritis, Knee

Interventions: Other: Video
Other: Shared Decision-Making Tool
Other: Standard of Care

First Posted Date: 2022-06-09

Last Posted Date: 2024-01-18

Lead Sponsor: Yale University

Target Recruit Count: 105

Registration Number: NCT05411939

Locations: 🇺🇸
Yale Medicine Multispecialty, Guilford, Connecticut, United States
🇺🇸
Yale Ortho Milford, Milford, Connecticut, United States
🇺🇸
Yale Ortho, New Haven, Connecticut, United States

Non-invasive Measurement of PD-L1 Levels With Positron Emission Tomography (PET) in Head and Neck Malignancies and Intracranial Metastases

Phase 1

Terminated

Conditions: Metastatic Cancer
Metastatic Lung Cancer
Cancer Head Neck

Interventions: Drug: adnectin 18F-BMS-986192 Head and Neck Cancer
Drug: adnectin 18F-BMS-986192 Brain Metastases

First Posted Date: 2022-06-07

Last Posted Date: 2024-02-15

Lead Sponsor: Yale University

Target Recruit Count: 7

Registration Number: NCT05408871

Locations: 🇺🇸
Yale University PET Center, New Haven, Connecticut, United States

LGBTQ-affirmative CBT for Youth

Not Applicable

Completed

Conditions: Anxiety Disorders
Depression
LGBTQ

Interventions: Behavioral: LGBTQ-affirmative cognitive behavioral group therapy

First Posted Date: 2022-06-07

Last Posted Date: 2024-05-31

Lead Sponsor: Yale University

Target Recruit Count: 9

Registration Number: NCT05408858

Locations: 🇺🇸
Dr. Pachankis' Lab, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy